EU Migraine Treatment Market, by Types of Migraine (Episodic, Migraine with Aura, Chronic and Others), by Treatment (Acute/Abortive Treatment, Prophylactic Treatment, Non-Pharmacological Therapies and Devices), by Drug type (Branded and Generic), by Route of Administration (Oral, Parental, Nasal Sprays and Others), by End User (Hospital, Homecare, Clinics, Others) and by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies and Others), by Drug Type (Branded and Generic) Growth, Trends and Forecast, 2019-2028
- Published Date: 2022-12-26
- Report ID: 138209
- Pages: 200
-
Format:
Report Overview
The EU Migraine treatment market size stood at round USD xx billion in 2019 and is projected to reach USD $2.8 billion by 2028, exhibiting a CAGR of xx% during the forecast period
Migraine is not the same as the usual kind of headaches that most people have every now and then. A migraine attack starts suddenly with severe pain on only one side of your head. The pain is much worse than a normal headache and usually accompanied by other symptoms as well
Market Drivers
Migraine treatment comprises features such as increasing R&D investment leading to pipeline products will impact in launching new product by the manufactures into the market which enhance its demand as well as increasing prevalence of migraine has enhanced the demand of migraine treatment. Currently various research studies are taking place which is expected to create a competitive advantage for manufacturers to develop innovative and advanced migraine treatment drugs which expected to provide various other opportunities in the migraine treatment market. However, adverse effects of drugs expected to restraint the market growth in the forecast period
1. EU Migraine Treatment Market Overview
A. Market Size
2. EU Migraine Treatment Growth Drivers
A. Increasing R&D investment leading to pipeline products will impact in launching new product
B. Increasing prevalence of migraine has enhanced the demand of migraine treatment
3. EU Migraine Treatment Segmentation.
A. By Migraine type
I. Episodic
II. Migraine with Aura
III. Chronic and Others
B. By Treatment
I. Acute/Abortive Treatment
II. Prophylactic Treatment
III. Non-Pharmacological Therapies and Devices
C. By Route of Administration
I. Oral
II. Parental
III. Nasal Sprays
IV. Others
D. By End User
I. Hospital
II. Homecare
III. Clinics
IV. Others
E. By Distribution Channel
I. Hospital Pharmacies
II. Retail Pharmacies
III. Online Pharmacies
IV. Others
F. By Drug Type
I. Branded
II. Generic
4. EU Migraine Treatment Major Market Share
A. Market Analysis, Insights and Forecast by Revenue
5. Competitive Landscape
A. Major Players
B. Products in Pipeline
6. Key Company Profiles
A. Eli-Lilly Company overview, Product & Services, Strategies & Financials
B. Astra Zeneca Company overview, Product & Services, Strategies & Financials
C. Amgen Company overview, Product & Services, Strategies & Financials
7. Healthcare Policies and Regulatory Landscape.
A. Policy Changes and Reimbursement Scenario
8. Factors Driving Market Growth
A. Key Industry Developments
B. Mergers and Acquisitions
9. Market Opportunities and Future Trends
A. Market Opportunities
B. Future Trends
10. Conclusion
Call Us
( India toll free )
+91 835 605 0278
( US toll free )
+1 800 601 6071
Drop us an email at
sales@prudentmarkets.com
Get your pre and post sales queries resolved by our Subject matter experts.
We will assist you to customize the report to fit your research needs.
Our prime focus is to provide qualitative and accurate data.
Feel free to order a sample report before purchase.
Your personal and confidential information is safe and secured.
